BOSTON SCIENTIFIC CORP Quarterly Operating Income (Loss) in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Boston Scientific Corp quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q2 2024.
  • Boston Scientific Corp Operating Income (Loss) for the quarter ending June 30, 2024 was $520M, a 1.17% increase year-over-year.
  • Boston Scientific Corp Operating Income (Loss) for the twelve months ending June 30, 2024 was $2.47B, a 35.4% increase year-over-year.
  • Boston Scientific Corp annual Operating Income (Loss) for 2023 was $2.34B, a 42.1% increase from 2022.
  • Boston Scientific Corp annual Operating Income (Loss) for 2022 was $1.65B, a 37.5% increase from 2021.
  • Boston Scientific Corp annual Operating Income (Loss) for 2021 was $1.2B.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.47B $520M +$6M +1.17% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $2.47B $675M +$123M +22.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $2.34B $584M +$182M +45.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $2.16B $693M +$335M +93.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $1.83B $514M +$91M +21.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $1.74B $552M +$86M +18.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $1.65B $402M +$222M +123% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $1.43B $358M -$29M -7.49% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $1.46B $423M +$161M +61.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $1.3B $466M +$96M +25.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.2B $180M +$130M +260% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $1.07B $387M +$592M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $477M $262M +$333M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $144M $370M +$224M +153% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$80M $50M -$160M -76.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $80M -$205M -$588M -154% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $668M -$71M -$455M -118% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $1.12B $146M -$395M -73% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $1.52B $210M -$109M -34.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $1.63B $383M -$5M -1.29% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.63B $384M -$8M -2.04% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $1.64B $541M +$134M +32.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $1.51B $319M $0 0% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $1.51B $388M +$11M +2.92% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $1.5B $392M +$167M +74.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 $1.33B $407M +$43M +11.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 $1.29B $319M +$179M +128% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $1.11B $377M +$29M +8.33% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-29
Q2 2017 $1.08B $225M +$559M Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $518M $364M +$71M +24.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 $447M $140M +$367M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-19
Q3 2016 $80M $348M +$647M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$567M -$334M -$553M -253% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$14M $293M +$269M +1121% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$283M -$227M +$266M +54% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-20
Q3 2015 -$549M -$299M -$363M -567% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$186M $219M +$288M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 -$474M $24M -$173M -87.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 -$301M -$493M -$620M -488% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 $319M $64M -$39M -37.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $358M -$69M -$289M -131% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $647M $197M +$527M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $120M $127M +$10M +8.55% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-24
Q3 2013 $110M $103M +$697M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 -$587M $220M +$3.81B Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 -$4.39B -$330M -$526M -268% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$3.87B $117M -$54M -31.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 -$3.81B -$594M -$768M -441% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 -$3.05B -$3.59B -$3.82B -1614% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $778M $196M -$126M -39.1% Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-05-07
Q4 2011 $904M $171M -$178M -51% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-26
Q3 2011 $1.08B $174M -$77M -30.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $1.16B $237M +$6M +2.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $1.15B $322M +$1.81B Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
Q4 2010 -$655M $349M Oct 1, 2010 Dec 31, 2010 10-K 2011-02-17
Q3 2010 $251M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 $231M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
Q1 2010 -$1.49B Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.